AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

04.06.20	AstraZeneca targets 2 billion doses, poor countries with COVID vaccine deals (Reuters)
04.06.20	AstraZeneca targets two billion doses, poor countries with COVID vaccine deals (Reuters)
04.06.20	AstraZeneca aims at two billion doses with new COVID vaccine deals (Reuters)
04.06.20	AstraZeneca eyes over two billion doses of potential COVID-19 vaccine after deals (Reuters)
01.06.20	AstraZeneca scores twin drug approvals alongside vaccine progress (Reuters)
28.05.20	AstraZeneca says it may consider exposing vaccine trial participants to virus (Reuters)
28.05.20	AstraZeneca partners with Oxford Biomedica to expand COVID-19 vaccine manufacturing capacity (Reuters)
21.05.20	U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine (Reuters)
21.05.20	AstraZeneca to make billion COVID vaccine doses if tests succeed (Reuters)
21.05.20	AstraZeneca gets first supply deals for COVID vaccine, eyes late stage trials (Reuters)
30.04.20	AstraZeneca teams up with Oxford University to develop COVID-19 vaccine (Reuters)
30.04.20	AstraZeneca CEO says will know whether Oxford's vaccine works in June or July (Reuters)
30.04.20	AstraZeneca to make Oxford University's potential COVID-19 vaccine (Reuters)
30.04.20	AstraZeneca to produce Oxford University's potential COVID-19 vaccine (Reuters)
29.04.20	AstraZeneca sticks to 2020 outlook, boosted by drug stockpiling (Reuters)
29.04.20	AstraZeneca beats first-quarter profit estimates, retains 2020 forecast (Reuters)
23.04.20	AstraZeneca pilots diabetes drug as potential COVID-19 treatment (Reuters)
23.04.20	AstraZeneca tests diabetes drug as possible COVID-19 treatment (Reuters)
23.04.20	AstraZeneca trials Farxiga as potential treatment for COVID-19 patients (Reuters)
14.04.20	AstraZeneca to test impact of cancer drug Calquence on coronavirus patients (Reuters)
14.04.20	AstraZeneca to start Calquence in COVID-19 trial (Reuters)
08.04.20	UK coronavirus testing capacity boosted by new AstraZeneca, GSK lab (Reuters)
30.03.20	AstraZeneca scores win as diabetes drug shown to slow kidney disease (Reuters)
14.02.20	AstraZeneca braces for coronavirus hit, but no impact so far (Reuters)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V